Results 31 to 40 of about 8,824 (191)

Behandlungsoptionen für Molluscum contagiosum: Eine systematische Übersicht [PDF]

open access: yesJ Dtsch Dermatol Ges
Zusammenfassung Molluscum contagiosum (MC) ist eine virale Hautinfektion mit erheblichen physischen und psychosozialen Belastungen, die insbesondere bei Kindern und Personen mit geschwächtem Immunsystem auftritt. Obwohl mehrere Behandlungsoptionen zur Verfügung stehen, sind vergleichende Daten zu deren Wirksamkeit und Sicherheit begrenzt.
Wang O   +3 more
europepmc   +2 more sources

Treatment of warts with topical cidofovir in a pediatric patient [PDF]

open access: yes, 2019
Cidofovir is an antiviral nucleotide analogue with relatively new treatment capacities for dermatological conditions, specifically verruca vulgaris caused by human papilloma virus infection.
Sergeyenko, Artem   +2 more
core   +1 more source

A Multimodal Treatment Strategy to Manage Severe Cutaneous Mpox

open access: yesAnnals of Internal Medicine: Clinical Cases
A 33-year-old bisexual man with advanced HIV and severe mpox developed severe cutaneous disease despite receiving tecovirimat, antiretroviral therapy, and vaccinia immune globulin.
Navin Bhatt   +6 more
doaj   +1 more source

Historical Perspectives in the Development of Antiviral Agents Against Poxviruses

open access: yesViruses, 2010
The poxvirus vaccinia virus (VV) served as the model virus for which the first antivirals, the thiosemicarbazones, were identified. This dates back to 1950; and, although there is at present no single antiviral drug specifically licensed for the ...
Erik De Clercq
doaj   +1 more source

Cidofovir effects on recurrent laryngeal papillomatosis in children: preliminary report [PDF]

open access: yes, 2004
AIM: To demonstrate the effects of local application of Cidofovir in children with recurrent laryngeal papillomatosis (RLP), according to our 2002 institutional protocol for RLP management. STUDY DESIGN: Preliminary/clinical prospective.
Gutzman, Raquel L.   +23 more
core   +2 more sources

Airway Papillomatosis: New Treatments for an Old Challenge

open access: yesFrontiers in Pediatrics, 2019
Recurrent respiratory papillomatosis (RRP) is the recurrent growth of small, benign tumors, or papillomas, in the respiratory tract, caused by human papillomavirus (HPV). Currently, there is no cure.
Nankee Kumar   +2 more
doaj   +1 more source

Long‐term outcomes of haploidentical hematopoietic stem cell transplantation with antithymocyte globulin–based myeloablative conditioning in pediatric refractory or relapsed non‐Hodgkin lymphoma

open access: yesPediatric Investigation, EarlyView.
Single‐center retrospective data showed that ATG‐based myeloablative haploidentical hematopoietic stem cell transplantation provides durable remission and favorable long‐term survival in children with refractory/relapsed non‐Hodgkin lymphoma, achieving high engraftment rates, low relapse incidence, and acceptable toxicity.
Chenguang Jia   +12 more
wiley   +1 more source

Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. [PDF]

open access: yes, 2007
Invasive adenovirus (AdV) disease is fatal in \u3e50% of allogeneic hematopoietic stem cell transplant (SCT) recipients. Treatment with cidofovir may improve outcomes based on in vitro susceptibility data and case reports.
Filicko, Joanne   +10 more
core   +3 more sources

Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis

open access: yesBMC Pediatrics, 2011
Background Infection with varicella-zoster virus (VZV) contemporaneously with malignant disease or immunosuppression represents a particular challenge and requires individualized decisions and treatment.
Liese Johannes   +8 more
doaj   +1 more source

ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Despite pre‐emptive treatment (PeT), cytomegalovirus (CMV) disease and reactivation remain a clinical concern. In Australia and New Zealand (ANZ), variability exists in the management of CMV for haematopoietic stem cell transplantation (HSCT) recipients.
Andrea Henden   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy